Cargando…
Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
Hepatitis C virus (HCV) infects more than 2 % of the world population with highest prevalence in parts of Africa and Asia. Past standard of care using interferon α and ribavirin had adverse effects and showed modest efficacy for some HCV genotypes spurring the development of direct acting antivirals...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089091/ https://www.ncbi.nlm.nih.gov/pubmed/32214912 http://dx.doi.org/10.1007/s11901-013-0187-1 |